Impact of diabetes and metformin use on prostate cancer

Scand J Urol. 2020 Dec;54(6):508-509. doi: 10.1080/21681805.2020.1806355. Epub 2020 Aug 13.

Authors

Daniel Taussky^{1

2}, Guila Delouya^{1

2}

Affiliations

¹ Department of Radiation Oncology, University of Montreal Health Center, Montreal, Canada.
² CRCHUM-Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Canada.

PMID: 32787660
DOI: 10.1080/21681805.2020.1806355

No abstract available

Publication types

Editorial

MeSH terms

Diabetes Mellitus, Type 2* / complications
Diabetes Mellitus, Type 2* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Male
Metformin* / therapeutic use
Prostatic Neoplasms* / complications
Prostatic Neoplasms* / drug therapy

Substances

Hypoglycemic Agents
Metformin